Home : Unsafe Drugs : Avelox : Newsfeeds

Avelox - Newsfeeds

Gentium Announces Completion of Preclinical and Clinical Studies for Defibrotide
The expected effect on the QT/QTc interval was observed with moxifloxacin as a positive control. Also in line with previous studies, plasma pharmacokinetics in these healthy volunteers typically showed that Defibrotide had short half-life dose-dependent ...
Research and Markets: Moxifloxacin - Comprehensive Patent Search
Research and Markets ( http://www.researchandmarkets.com/research/da22f6/moxifloxacin_com ) has announced the addition of the " Moxifloxacin - Comprehensive patent search " report to their offering. Eliminate unnecessary risk with the industry benchmark in ...
Merck Announces Fourth Quarter and Full Year 2010 Financial Results
"Merck today reported a high quality fourth quarter characterized by strong revenue performance, significant cost reductions and double-digit earnings growth," said Kenneth C. Frazier, president and chief executive officer. "These results clearly ...
Research and Markets: Moxifloxacin - Comprehensive Patent Search
DUBLIN--(BUSINESS WIRE)-- Research and Markets ( http://www.researchandmarkets.com/research/da22f6/moxifloxacin_com ) has announced the addition of the " Moxifloxacin - Comprehensive patent search " report to their offering. Pipeline Developer is a ...
OPTR-Astellas Pact for Fidaxomicin
We believe Astellas will be an ideal partner for Optimer in Europe because of prior experience in commercializing anti-infective drugs like Mycamine, Avelox, Vivotif, and isavuconazole. Currently, we have a Neutral recommendation on Optimer, which is ...
Vancomycin Inj
Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Renal insufficiency. Monitor hearing, blood, renal function. Monitor vancomycin serum concentrations closely. Elderly. Debilitated. Pregnancy (Cat.C ...
Patient Discussions:
Patient Discussions are not a substitute for professional medical advice, diagnosis, or treatment. Never delay or disregard seeking professional medical advice from your physician or other qualified health provider because of something you have read on ...
Dusting Off Old TB Drug May Promote Faster Treatment
The researchers also substituted moxifloxacin (Avelox) for isoniazid (Nydrazid), but that change was less important in improving the response than switching the rifamycin drugs, Dr. Nuermberger and colleagues said. The standard regimen for drug-susceptible ...
Rib-X Announces Publication Demonstrating Superior Infection Site Potency for Delafloxacin against Gram ...
NEW HAVEN, Ct. - (BUSINESS WIRE) - Rib-X Pharmaceuticals, Inc. , an antibiotics company with a broad development-stage pipeline, today announced the publication of positive preclinical data for delafloxacin highlighting the candidate's superior infection ...
Generic Erosion Of Nine Branded Agents Will Significantly Constrain Growth In The Hospital-Acquired ...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the generic erosion of nine branded agents will significantly constrain growth in the hospital-acquired infections (HAI) drug ...
Why an exhibition bench?
The market information as it is considered to be, subconsciously tr ansmits behavioural targeting, realising social responsibility of business. A consumer society, analysing results of an advertising campaign, it is achievable in reasonable terms. The ...
Antibiotics and Blood Pressure Drug Combos Dangerous to Older Adults
Some blood pressure drugs and antibiotics , when combined, could cause dangerously low blood pressure in older adults, according to the findings of a new study.  Blood pressure medications known as calcium-channel blockers can cause hypotension when ...
John Duddy vs. Matt Vanda
There's no question who has home court advantage in this middleweight fight as the crowd went crazy when Ireland's John Duddy was introduced by ring announcer Michael Buffer. Round 1: Vanda held his own, but Duddy was the more active of the two and landed ...
Patient Discussions:
Patient Discussions are not a substitute for professional medical advice, diagnosis, or treatment. Never delay or disregard seeking professional medical advice from your physician or other qualified health provider because of something you have read on ...
Items in AFP with MESH term: Urinary Tract Infections
Quinolones: A Comprehensive Review - Article ABSTRACT: With the recent introduction of agents such as gatifloxacin and moxifloxacin, the traditional gram-negative coverage of fluoroquinolones has been expanded to include specific gram-positive organisms.
Alcon Posts Solid Fourth Quarter Financial Results
Sales increased 10.5 percent to $7.18 billion (+8.6 percent organic growth) Adjusted diluted EPS increased 13.2 percent to $7.71 (+9.2 percent to $7.27 reported) Sales in emerging markets rose 21.3 percent Glaucoma pharmaceutical sales increased 13.9 ...
Moxifloxacin (Ophthalmic Route)
Moxifloxacin belongs to the family of medicines called antibiotics. Moxifloxacin ophthalmic solution (eye drops) is used to treat infections of the eye, such as bacterial conjunctivitis. Ophthalmic moxifloxacin works by killing the bacteria in your eye ...
Eye Bacteria Susceptible to Newer Antibiotics
Of bacteria cultured from the eyes of patients about to undergo refractive surgery -- predominantly coagulase-negative staphylococci (CNS) -- few were resistant to gatifloxacin (Zymar) and moxifloxacin, and none were resistant to gemifloxacin (Factive ...
Moxifloxacin (Oral Route)
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific ...
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
The first trial will be conducted to reinforce safety and test efficacy of their first sustained drug delivery system, a moxifloxacin-loaded punctum plug. Following, Ocular Therapeutix plans to initiate additional Phase II clinical trials for punctum plugs ...
Looking for a Washington, DC Avelox attorney? Get in touch with one of our Washington, DC Avelox attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: Previous   1   2   3   4   5   6   7   8   9   10   11   ...   Next

Need An Avelox Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a Washington, DC Avelox attorney? Get in touch with one of our Washington, DC Avelox attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Avelox Case - Submit Your Information Below

Do you need legal assistance with your Avelox case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Avelox Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.